For patients
Patient resources
Resources designed around you
Learn more about the Oncodetect™ Molecular Residual Disease (MRD) test with tools to help you and your doctor make decisions about your cancer care.
The Oncodetect MRD test can help you stay one step ahead
The Oncodetect MRD test can help you stay one step ahead
MRD testing can provide valuable insights into your cancer’s activity. Get to know the Oncodetect MRD test, read about the testing process, learn about possible results, and more.
Patient resources
Oncodetect MRD test patient brochure
PDF
Read about the benefits of MRD testing, the Oncodetect MRD testing process, possible results, and more.
Blood draw instructions
PDF
Learn about your blood draw options, including affiliated lab locations and mobile phlebotomy.
Understanding your test report
PDF
Find out what you can expect when you get your Oncodetect MRD test results back, with an overview of possible results plus annotated sample reports.
“Talk to your doc” guide
PDF
Get helpful questions and talking points for speaking with your doctor about MRD testing and the benefits of the Oncodetect MRD test.
Patient education video
Learn about the benefits of MRD testing, the Oncodetect MRD testing process, possible results, and more.
Have questions?
Call us at +1 888-662-6897 .
References and footnotes
This test was developed, and its performance characteristics determined by Genomic Health, Inc. The Oncodetect test was clinically validated in colorectal cancer patients with stage II-IV disease. Performance characteristics may not apply in tumor types not included in this test’s clinical validation. The test has not been cleared or approved by the US Food and Drug Administration. The test has been validated as a Laboratory Developed Test per institutional and applicable CLIA regulation (CLIA# 03D2048606) and College of American Pathology (CAP# 8869063) as qualified to perform high complexity clinical laboratory testing.